United States 3D bioprinting market size is projected to exhibit a growth rate (CAGR) of 13.40% during 2024-2032. The escalating demand for this technology that can revolutionize personalized medicine, tissue engineering, and organ transplantation has spurred investments and collaborations across academia, healthcare institutions, and industry players, which is primarily driving the market growth.
